8-K: Healthcare Realty Trust Reports Mixed Q4 Results, Announces Dividend

Healthcare Realty Trust reported a net loss for Q4 2024 but achieved normalized FFO per share at the high end of guidance and announced a quarterly dividend of $0.31 per share.

Summary

• Healthcare Realty Trust Incorporated (HR) announced its fourth-quarter results for the period ended December 31, 2024.
• The company reported a net loss attributable to common stockholders of $(106.8) million, or $(0.31) per diluted common share for the quarter.
• Normalized FFO per share totaled $0.40 for the quarter, which was at the high end of the previously provided guidance range, representing a 2.5% increase over the prior year period.
• For the year ended December 31, 2024, normalized FFO per share was $1.56.
• The company announced a quarterly dividend of $0.31 per share and operating partnership unit.
• Same-store cash NOI increased by 3.1% for the quarter and 2.9% for the year; excluding the impact of Steward Health and Prospect Medical, the growth would have been 3.6% and 3.1%, respectively.
• The company closed joint venture and asset sale transactions totaling $522 million in the fourth quarter, generating approximately $1.3 billion of proceeds for the year.
• For the year, the company repurchased approximately 31 million shares totaling $510 million at an average price of $16.56 per share.
• The company repaid its $350 million term loan maturing in 2025 and ended the year with leverage at 6.4 times net debt to adjusted EBITDA.
• The company's 2025 same-store cash NOI growth estimated guidance range is 3.00% to 3.75%, excluding the impact of Prospect Medical and Steward Health.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While the company reported a net loss, it also achieved normalized FFO per share at the high end of guidance and announced a dividend. The company is actively managing its portfolio through joint ventures and asset sales, and addressing tenant risks.

Positives

• Normalized FFO per share was at the high end of the guidance range.
• The company achieved a new single-quarter high in signed new leases.
• The company made significant progress re-leasing space previously occupied by Steward Health.
• The company ended the year with leverage at 6.4 times net debt to adjusted EBITDA.
• The company has $1.5 billion of availability on its revolving credit facility.

Negatives

• Net loss attributable to common stockholders for Q4 2024 was $(106.8) million, or $(0.31) per diluted common share.
• Prospect Medical filed for Chapter 11 bankruptcy protection, impacting approximately $2.9 million of annual revenue.
• The 2025 guidance excludes the impact of Prospect Medical and Steward Health.

Risks

• The company's expected results may not be achieved.
• Failure to realize the expected benefits of the Merger.
• General adverse economic and local real estate conditions.
• Changes in economic conditions generally and the real estate market specifically.
• Legislative and regulatory changes, including changes to laws governing the taxation of REITs and changes to laws governing the healthcare industry.
• The availability of capital.
• Changes in interest rates.
• Competition in the real estate industry.
• The supply and demand for operating properties in the company's proposed market areas.
• Changes in accounting principles generally accepted in the US.
• Policies and guidelines applicable to REITs.
• The availability of properties to acquire.
• The availability of financing.
• Pandemics and other health concerns, and the measures intended to prevent their spread and the potential material adverse effect these matters may have on the company's business, results of operations, cash flows and financial condition.

Future Outlook

The company's 2025 same-store cash NOI growth is estimated to be in the range of 3.00% to 3.75%, excluding the impact of Prospect Medical and Steward Health.

Industry Context

This announcement reflects the ongoing trends in the healthcare REIT sector, including a focus on medical outpatient buildings, managing tenant risks (such as bankruptcies), and optimizing capital allocation through joint ventures and asset sales.

Comparison to Industry Standards

• The company's focus on medical outpatient buildings aligns with the broader trend in healthcare towards outpatient services, similar to companies like Physicians Realty Trust (DOC) and Healthcare Trust of America (HTA) prior to its merger with HR.
• The reported net debt to adjusted EBITDA of 6.4x is within a reasonable range for REITs, but investors will likely compare this to peers like Ventas (VTR) and Welltower (WELL) to assess relative leverage.
• The same-store NOI growth of 3.1% is a key metric, and analysts will compare this to the performance of other healthcare REITs to determine if HR is outperforming or underperforming its peers.
• The company's strategy of forming joint ventures to recycle capital is a common practice in the REIT industry, similar to strategies employed by other large REITs like Simon Property Group (SPG) and Prologis (PLD).

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders will receive a quarterly dividend of $0.31 per share.
• Employees will experience leadership changes with the appointment of an Interim President & CEO and a new CFO.
• Tenants may be affected by the company's management of its portfolio and its response to tenant bankruptcies.
• Creditors will be interested in the company's debt metrics and its ability to repay its obligations.

Next Steps

• The company will hold a conference call on February 19, 2025, to discuss earnings results, quarterly activities, general operations, and industry trends.
• The search committee will continue its search for a permanent President & Chief Executive Officer.

Key Dates

Keywords

Healthcare Realty Trust, REIT, Medical Outpatient Buildings, FFO, NOI, Dividend, Leasing, Occupancy, Debt, EBITDA, Joint Venture, Asset Sales, Share Repurchase, Guidance, Steward Health, Prospect Medical